Ong J, Kerr D I
Department of Anaesthesia and Intensive Care, The University of Adelaide, Adelaide, South Australia 5005, Australia.
Eur J Pharmacol. 1995 Dec 12;287(2):197-200. doi: 10.1016/0014-2999(95)00659-1.
Interactions of N-ethylmaleimide and aluminium fluoride (AlF - 4) with GABAB receptors have been examined using spontaneously discharging rat neocortical slices. The suppression of discharges by the GABAB receptor agonist baclofen (5-10 mu M) was irreversibly prevented by N-ethylmaleimide (10-50 mu M) and its analog N-phenylmaleimide (10-50 mu M), whilst superfusion of slices with NaF (10 mM) and AlCl3 (100 mu M) to form a fluoroaluminate (AlF - 4) complex markedly potentiated the action of baclofen. The lipoxygenase inhibitors, nordihydroguaiaretic acid (10-50 mu M) and eicosatetraynoic acid (10-50 mu M) or the phospholipase A2 inhibitor bromophenacylbromide (50-100 mu M) did not affect the response to baclofen. The depressant action of baclofen is evidently mediated through G-proteins, but is not dependent on arachidonic acid metabolites.
利用自发放电的大鼠新皮质切片,研究了N-乙基马来酰亚胺和氟化铝(AlF₄⁻)与GABAB受体的相互作用。GABAB受体激动剂巴氯芬(5 - 10 μM)对放电的抑制作用可被N-乙基马来酰亚胺(10 - 50 μM)及其类似物N-苯基马来酰亚胺(10 - 50 μM)不可逆地阻断,而用NaF(10 mM)和AlCl₃(100 μM)对切片进行灌流以形成氟铝酸盐(AlF₄⁻)复合物,则显著增强了巴氯芬的作用。脂氧合酶抑制剂去甲二氢愈创木酸(10 - 50 μM)和二十碳四烯酸(10 - 50 μM)或磷脂酶A2抑制剂溴苯甲酰溴(50 - 100 μM)不影响对巴氯芬的反应。巴氯芬的抑制作用显然是通过G蛋白介导的,但不依赖于花生四烯酸代谢产物。